?>
Plan Name | WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN |
Plan identification number | 008 |
401k Plan Type | Defined Contribution Pension |
Plan Features/Benefits |
|
Company Name: | WEST PHARMACEUTICAL SERVICES, INC. |
Employer identification number (EIN): | 231210010 |
NAIC Classification: | 339110 |
Additional information about WEST PHARMACEUTICAL SERVICES, INC.
Jurisdiction of Incorporation: | Texas Secretary of State |
Incorporation Date: | 1990-06-01 |
Company Identification Number: | 0008421106 |
Legal Registered Office Address: |
101 GORDON DR EXTON United States of America (USA) 19341 |
More information about WEST PHARMACEUTICAL SERVICES, INC.
Plan id# | Filing Submission Date | Name of Administrator | Date Administrator Signed | Name of Company Sponsor | Date Sponsor Signed |
---|---|---|---|---|---|
008 | 2022-01-01 | ||||
008 | 2021-01-01 | ||||
008 | 2020-01-01 | ||||
008 | 2019-01-01 | ||||
008 | 2018-01-01 | ANNETTE FAVORITE | ANNETTE FAVORITE | 2019-07-22 | |
008 | 2017-01-01 | ANNETTE FAVORITE | ANNETTE FAVORITE | 2018-06-29 | |
008 | 2016-01-01 | ANNETTE FAVORITE | ANNETTE FAVORITE | 2017-07-13 | |
008 | 2015-01-01 | ANNETTE FAVORITE | ANNETTE FAVORITE | 2016-07-27 | |
008 | 2014-01-01 | WILLIAM FEDERICI | WILLIAM FEDERICI | 2015-07-30 | |
008 | 2013-01-01 | RICHARD D. LUZZI | RICHARD D. LUZZI | 2014-07-21 | |
008 | 2012-01-01 | RICHARD D. LUZZI | RICHARD D. LUZZI | 2013-07-22 | |
008 | 2011-01-01 | RICHARD D. LUZZI | RICHARD D. LUZZI | 2012-08-01 | |
008 | 2010-01-01 | RICHARD LUZZI | |||
008 | 2009-01-01 | RICHARD LUZZI |
Measure | Date | Value |
---|---|---|
2022: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2022 401k membership | ||
Total participants, beginning-of-year | 2022-01-01 | 5,147 |
Total number of active participants reported on line 7a of the Form 5500 | 2022-01-01 | 4,447 |
Number of retired or separated participants receiving benefits | 2022-01-01 | 4 |
Number of other retired or separated participants entitled to future benefits | 2022-01-01 | 1,076 |
Total of all active and inactive participants | 2022-01-01 | 5,527 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2022-01-01 | 23 |
Total participants | 2022-01-01 | 5,550 |
Number of participants with account balances | 2022-01-01 | 5,458 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2022-01-01 | 436 |
2021: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2021 401k membership | ||
Total participants, beginning-of-year | 2021-01-01 | 4,604 |
Total number of active participants reported on line 7a of the Form 5500 | 2021-01-01 | 4,149 |
Number of retired or separated participants receiving benefits | 2021-01-01 | 2 |
Number of other retired or separated participants entitled to future benefits | 2021-01-01 | 976 |
Total of all active and inactive participants | 2021-01-01 | 5,127 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2021-01-01 | 20 |
Total participants | 2021-01-01 | 5,147 |
Number of participants with account balances | 2021-01-01 | 4,959 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2021-01-01 | 415 |
2020: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2020 401k membership | ||
Total participants, beginning-of-year | 2020-01-01 | 3,729 |
Total number of active participants reported on line 7a of the Form 5500 | 2020-01-01 | 3,939 |
Number of retired or separated participants receiving benefits | 2020-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2020-01-01 | 653 |
Total of all active and inactive participants | 2020-01-01 | 4,592 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2020-01-01 | 12 |
Total participants | 2020-01-01 | 4,604 |
Number of participants with account balances | 2020-01-01 | 4,483 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2020-01-01 | 180 |
2019: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2019 401k membership | ||
Total participants, beginning-of-year | 2019-01-01 | 3,506 |
Total number of active participants reported on line 7a of the Form 5500 | 2019-01-01 | 3,152 |
Number of retired or separated participants receiving benefits | 2019-01-01 | 1 |
Number of other retired or separated participants entitled to future benefits | 2019-01-01 | 569 |
Total of all active and inactive participants | 2019-01-01 | 3,722 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2019-01-01 | 7 |
Total participants | 2019-01-01 | 3,729 |
Number of participants with account balances | 2019-01-01 | 3,649 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2019-01-01 | 179 |
2018: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2018 401k membership | ||
Total participants, beginning-of-year | 2018-01-01 | 3,723 |
Total number of active participants reported on line 7a of the Form 5500 | 2018-01-01 | 2,985 |
Number of retired or separated participants receiving benefits | 2018-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2018-01-01 | 513 |
Total of all active and inactive participants | 2018-01-01 | 3,498 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2018-01-01 | 8 |
Total participants | 2018-01-01 | 3,506 |
Number of participants with account balances | 2018-01-01 | 3,430 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2018-01-01 | 126 |
2017: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2017 401k membership | ||
Total participants, beginning-of-year | 2017-01-01 | 3,636 |
Total number of active participants reported on line 7a of the Form 5500 | 2017-01-01 | 3,330 |
Number of retired or separated participants receiving benefits | 2017-01-01 | 1 |
Number of other retired or separated participants entitled to future benefits | 2017-01-01 | 386 |
Total of all active and inactive participants | 2017-01-01 | 3,717 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2017-01-01 | 6 |
Total participants | 2017-01-01 | 3,723 |
Number of participants with account balances | 2017-01-01 | 2,712 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2017-01-01 | 0 |
2016: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2016 401k membership | ||
Total participants, beginning-of-year | 2016-01-01 | 3,467 |
Total number of active participants reported on line 7a of the Form 5500 | 2016-01-01 | 3,287 |
Number of retired or separated participants receiving benefits | 2016-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2016-01-01 | 343 |
Total of all active and inactive participants | 2016-01-01 | 3,630 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2016-01-01 | 6 |
Total participants | 2016-01-01 | 3,636 |
Number of participants with account balances | 2016-01-01 | 2,323 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2016-01-01 | 1 |
2015: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2015 401k membership | ||
Total participants, beginning-of-year | 2015-01-01 | 3,330 |
Total number of active participants reported on line 7a of the Form 5500 | 2015-01-01 | 3,138 |
Number of retired or separated participants receiving benefits | 2015-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2015-01-01 | 324 |
Total of all active and inactive participants | 2015-01-01 | 3,462 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2015-01-01 | 5 |
Total participants | 2015-01-01 | 3,467 |
Number of participants with account balances | 2015-01-01 | 2,214 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2015-01-01 | 0 |
2014: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2014 401k membership | ||
Total participants, beginning-of-year | 2014-01-01 | 3,255 |
Total number of active participants reported on line 7a of the Form 5500 | 2014-01-01 | 3,016 |
Number of retired or separated participants receiving benefits | 2014-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2014-01-01 | 310 |
Total of all active and inactive participants | 2014-01-01 | 3,326 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2014-01-01 | 4 |
Total participants | 2014-01-01 | 3,330 |
Number of participants with account balances | 2014-01-01 | 2,125 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2014-01-01 | 1 |
2013: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2013 401k membership | ||
Total participants, beginning-of-year | 2013-01-01 | 3,153 |
Total number of active participants reported on line 7a of the Form 5500 | 2013-01-01 | 2,939 |
Number of retired or separated participants receiving benefits | 2013-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2013-01-01 | 312 |
Total of all active and inactive participants | 2013-01-01 | 3,251 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2013-01-01 | 4 |
Total participants | 2013-01-01 | 3,255 |
Number of participants with account balances | 2013-01-01 | 2,050 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2013-01-01 | 0 |
2012: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2012 401k membership | ||
Total participants, beginning-of-year | 2012-01-01 | 3,196 |
Total number of active participants reported on line 7a of the Form 5500 | 2012-01-01 | 2,822 |
Number of retired or separated participants receiving benefits | 2012-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2012-01-01 | 328 |
Total of all active and inactive participants | 2012-01-01 | 3,150 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2012-01-01 | 3 |
Total participants | 2012-01-01 | 3,153 |
Number of participants with account balances | 2012-01-01 | 1,980 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2012-01-01 | 0 |
2011: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2011 401k membership | ||
Total participants, beginning-of-year | 2011-01-01 | 3,334 |
Total number of active participants reported on line 7a of the Form 5500 | 2011-01-01 | 2,819 |
Number of retired or separated participants receiving benefits | 2011-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2011-01-01 | 373 |
Total of all active and inactive participants | 2011-01-01 | 3,192 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2011-01-01 | 4 |
Total participants | 2011-01-01 | 3,196 |
Number of participants with account balances | 2011-01-01 | 1,981 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2011-01-01 | 40 |
2010: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2010 401k membership | ||
Total participants, beginning-of-year | 2010-01-01 | 2,458 |
Total number of active participants reported on line 7a of the Form 5500 | 2010-01-01 | 2,977 |
Number of retired or separated participants receiving benefits | 2010-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2010-01-01 | 354 |
Total of all active and inactive participants | 2010-01-01 | 3,331 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2010-01-01 | 3 |
Total participants | 2010-01-01 | 3,334 |
Number of participants with account balances | 2010-01-01 | 2,005 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2010-01-01 | 47 |
2009: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2009 401k membership | ||
Total participants, beginning-of-year | 2009-01-01 | 2,424 |
Total number of active participants reported on line 7a of the Form 5500 | 2009-01-01 | 2,064 |
Number of retired or separated participants receiving benefits | 2009-01-01 | 0 |
Number of other retired or separated participants entitled to future benefits | 2009-01-01 | 391 |
Total of all active and inactive participants | 2009-01-01 | 2,455 |
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits | 2009-01-01 | 3 |
Total participants | 2009-01-01 | 2,458 |
Number of participants with account balances | 2009-01-01 | 2,050 |
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested | 2009-01-01 | 36 |
Measure | Date | Value |
---|---|---|
2022 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2022 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2022-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
Total income from all sources (including contributions) | 2022-12-31 | $-51,049,507 |
Total loss/gain on sale of assets | 2022-12-31 | $0 |
Total of all expenses incurred | 2022-12-31 | $51,465,382 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $51,259,384 |
Expenses. Certain deemed distributions of participant loans | 2022-12-31 | $5,228 |
Value of total corrective distributions | 2022-12-31 | $511 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $71,971,262 |
Value of total assets at end of year | 2022-12-31 | $412,346,793 |
Value of total assets at beginning of year | 2022-12-31 | $514,861,682 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $200,259 |
Total interest from all sources | 2022-12-31 | $236,307 |
Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $13,845,820 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $13,845,820 |
Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
Value of fidelity bond cover | 2022-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
Contributions received from participants | 2022-12-31 | $22,365,899 |
Participant contributions at end of year | 2022-12-31 | $5,615,895 |
Participant contributions at beginning of year | 2022-12-31 | $4,839,458 |
Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $28,618,436 |
Administrative expenses (other) incurred | 2022-12-31 | $200,259 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Value of net income/loss | 2022-12-31 | $-102,514,889 |
Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $412,346,793 |
Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $514,861,682 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $181,177,464 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $387,011,261 |
Interest on participant loans | 2022-12-31 | $236,307 |
Value of interest in master investment trust accounts at end of year | 2022-12-31 | $50,070,553 |
Value of interest in master investment trust accounts at beginning of year | 2022-12-31 | $114,206,124 |
Value of interest in common/collective trusts at end of year | 2022-12-31 | $165,319,508 |
Value of interest in common/collective trusts at beginning of year | 2022-12-31 | $0 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-83,848,088 |
Net investment gain or loss from common/collective trusts | 2022-12-31 | $135,249 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
Contributions received in cash from employer | 2022-12-31 | $20,986,927 |
Employer contributions (assets) at end of year | 2022-12-31 | $10,163,373 |
Employer contributions (assets) at beginning of year | 2022-12-31 | $8,804,839 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $51,259,384 |
Did the plan have assets held for investment | 2022-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
Accountancy firm name | 2022-12-31 | FISCHER CUNNANE & ASSOCIATES, LTD |
Accountancy firm EIN | 2022-12-31 | 233060583 |
2021 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2021 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2021-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
Total income from all sources (including contributions) | 2021-12-31 | $142,828,205 |
Total loss/gain on sale of assets | 2021-12-31 | $0 |
Total of all expenses incurred | 2021-12-31 | $46,756,769 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $46,521,617 |
Expenses. Certain deemed distributions of participant loans | 2021-12-31 | $59,440 |
Value of total corrective distributions | 2021-12-31 | $3,885 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $42,087,045 |
Value of total assets at end of year | 2021-12-31 | $514,861,682 |
Value of total assets at beginning of year | 2021-12-31 | $418,790,246 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $171,827 |
Total interest from all sources | 2021-12-31 | $220,033 |
Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $14,472,547 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $14,472,547 |
Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
Value of fidelity bond cover | 2021-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
Contributions received from participants | 2021-12-31 | $19,241,000 |
Participant contributions at end of year | 2021-12-31 | $4,839,458 |
Participant contributions at beginning of year | 2021-12-31 | $4,361,761 |
Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $4,774,568 |
Administrative expenses (other) incurred | 2021-12-31 | $171,827 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Value of net income/loss | 2021-12-31 | $96,071,436 |
Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $514,861,682 |
Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $418,790,246 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $387,011,261 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $321,366,219 |
Interest on participant loans | 2021-12-31 | $220,033 |
Value of interest in master investment trust accounts at end of year | 2021-12-31 | $114,206,124 |
Value of interest in master investment trust accounts at beginning of year | 2021-12-31 | $85,146,523 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $35,898,516 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
Contributions received in cash from employer | 2021-12-31 | $18,071,477 |
Employer contributions (assets) at end of year | 2021-12-31 | $8,804,839 |
Employer contributions (assets) at beginning of year | 2021-12-31 | $7,915,743 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $46,521,617 |
Did the plan have assets held for investment | 2021-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
Accountancy firm name | 2021-12-31 | FISCHER CUNNANE & ASSOCIATES, LTD |
Accountancy firm EIN | 2021-12-31 | 233060583 |
2020 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2020 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2020-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
Total income from all sources (including contributions) | 2020-12-31 | $128,797,403 |
Total loss/gain on sale of assets | 2020-12-31 | $0 |
Total of all expenses incurred | 2020-12-31 | $35,716,029 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $35,609,086 |
Expenses. Certain deemed distributions of participant loans | 2020-12-31 | $-36,145 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $35,634,727 |
Value of total assets at end of year | 2020-12-31 | $418,790,246 |
Value of total assets at beginning of year | 2020-12-31 | $325,708,872 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $143,088 |
Total interest from all sources | 2020-12-31 | $238,783 |
Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $9,503,846 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $9,503,846 |
Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
Value of fidelity bond cover | 2020-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
Contributions received from participants | 2020-12-31 | $16,323,206 |
Participant contributions at end of year | 2020-12-31 | $4,361,761 |
Participant contributions at beginning of year | 2020-12-31 | $4,368,536 |
Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $3,603,712 |
Administrative expenses (other) incurred | 2020-12-31 | $143,088 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Value of net income/loss | 2020-12-31 | $93,081,374 |
Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $418,790,246 |
Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $325,708,872 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $321,366,219 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $261,748,855 |
Interest on participant loans | 2020-12-31 | $238,783 |
Value of interest in master investment trust accounts at end of year | 2020-12-31 | $85,146,523 |
Value of interest in master investment trust accounts at beginning of year | 2020-12-31 | $52,375,970 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $40,517,044 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
Contributions received in cash from employer | 2020-12-31 | $15,707,809 |
Employer contributions (assets) at end of year | 2020-12-31 | $7,915,743 |
Employer contributions (assets) at beginning of year | 2020-12-31 | $7,215,511 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $35,609,086 |
Did the plan have assets held for investment | 2020-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Unqualified |
Accountancy firm name | 2020-12-31 | FISCHER CUNNANE & ASSOCIATES, LTD |
Accountancy firm EIN | 2020-12-31 | 233060583 |
2019 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2019 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2019-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
Total income from all sources (including contributions) | 2019-12-31 | $99,750,628 |
Total loss/gain on sale of assets | 2019-12-31 | $0 |
Total of all expenses incurred | 2019-12-31 | $26,072,362 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $25,937,581 |
Expenses. Certain deemed distributions of participant loans | 2019-12-31 | $29,550 |
Value of total corrective distributions | 2019-12-31 | $1,199 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $29,769,731 |
Value of total assets at end of year | 2019-12-31 | $325,708,872 |
Value of total assets at beginning of year | 2019-12-31 | $252,030,606 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $104,032 |
Total interest from all sources | 2019-12-31 | $235,472 |
Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $10,181,658 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $10,181,658 |
Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
Value of fidelity bond cover | 2019-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
Contributions received from participants | 2019-12-31 | $14,577,111 |
Participant contributions at end of year | 2019-12-31 | $4,368,536 |
Participant contributions at beginning of year | 2019-12-31 | $4,068,711 |
Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $768,703 |
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2019-12-31 | $806 |
Administrative expenses (other) incurred | 2019-12-31 | $104,032 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Value of net income/loss | 2019-12-31 | $73,678,266 |
Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $325,708,872 |
Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $252,030,606 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $261,748,855 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $206,887,589 |
Interest on participant loans | 2019-12-31 | $235,472 |
Value of interest in master investment trust accounts at end of year | 2019-12-31 | $52,375,970 |
Value of interest in master investment trust accounts at beginning of year | 2019-12-31 | $39,198,785 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $39,672,962 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
Contributions received in cash from employer | 2019-12-31 | $14,423,917 |
Employer contributions (assets) at end of year | 2019-12-31 | $7,215,511 |
Employer contributions (assets) at beginning of year | 2019-12-31 | $1,875,521 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $25,936,775 |
Did the plan have assets held for investment | 2019-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Unqualified |
Accountancy firm name | 2019-12-31 | FISCHER CUNNANE & ASSOCIATES, LTD |
Accountancy firm EIN | 2019-12-31 | 233060583 |
2018 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2018 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2018-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
Total income from all sources (including contributions) | 2018-12-31 | $13,668,977 |
Total loss/gain on sale of assets | 2018-12-31 | $0 |
Total of all expenses incurred | 2018-12-31 | $25,802,950 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $25,682,495 |
Expenses. Certain deemed distributions of participant loans | 2018-12-31 | $14,415 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $24,829,119 |
Value of total assets at end of year | 2018-12-31 | $252,030,606 |
Value of total assets at beginning of year | 2018-12-31 | $264,164,579 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $106,040 |
Total interest from all sources | 2018-12-31 | $196,130 |
Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $7,821,913 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2018-12-31 | $7,821,913 |
Was this plan covered by a fidelity bond | 2018-12-31 | Yes |
Value of fidelity bond cover | 2018-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2018-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
Contributions received from participants | 2018-12-31 | $13,054,445 |
Participant contributions at end of year | 2018-12-31 | $4,068,711 |
Participant contributions at beginning of year | 2018-12-31 | $3,756,900 |
Income. Received or receivable in cash from other sources (including rollovers) | 2018-12-31 | $3,537,447 |
Administrative expenses (other) incurred | 2018-12-31 | $106,040 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Value of net income/loss | 2018-12-31 | $-12,133,973 |
Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $252,030,606 |
Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $264,164,579 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2018-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $206,887,589 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $195,624,241 |
Interest on participant loans | 2018-12-31 | $196,130 |
Value of interest in master investment trust accounts at end of year | 2018-12-31 | $39,198,785 |
Value of interest in master investment trust accounts at beginning of year | 2018-12-31 | $44,427,390 |
Value of interest in common/collective trusts at end of year | 2018-12-31 | $0 |
Value of interest in common/collective trusts at beginning of year | 2018-12-31 | $19,508,892 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-12-31 | $-19,589,157 |
Net investment gain or loss from common/collective trusts | 2018-12-31 | $322,789 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2018-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2018-12-31 | No |
Contributions received in cash from employer | 2018-12-31 | $8,237,227 |
Employer contributions (assets) at end of year | 2018-12-31 | $1,875,521 |
Employer contributions (assets) at beginning of year | 2018-12-31 | $847,156 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2018-12-31 | $25,682,495 |
Did the plan have assets held for investment | 2018-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2018-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2018-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2018-12-31 | Unqualified |
Accountancy firm name | 2018-12-31 | FISCHER CUNNANE & ASSOCIATES, LTD |
Accountancy firm EIN | 2018-12-31 | 233060583 |
2017 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2017 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2017-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
Total income from all sources (including contributions) | 2017-12-31 | $59,168,263 |
Total loss/gain on sale of assets | 2017-12-31 | $0 |
Total of all expenses incurred | 2017-12-31 | $27,888,856 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $27,799,725 |
Expenses. Certain deemed distributions of participant loans | 2017-12-31 | $9,941 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $19,615,400 |
Value of total assets at end of year | 2017-12-31 | $264,164,579 |
Value of total assets at beginning of year | 2017-12-31 | $232,885,172 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $79,190 |
Total interest from all sources | 2017-12-31 | $167,880 |
Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $13,520,031 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2017-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2017-12-31 | $13,520,031 |
Was this plan covered by a fidelity bond | 2017-12-31 | Yes |
Value of fidelity bond cover | 2017-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2017-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
Contributions received from participants | 2017-12-31 | $11,713,782 |
Participant contributions at end of year | 2017-12-31 | $3,756,900 |
Participant contributions at beginning of year | 2017-12-31 | $3,800,942 |
Income. Received or receivable in cash from other sources (including rollovers) | 2017-12-31 | $1,438,777 |
Administrative expenses (other) incurred | 2017-12-31 | $79,190 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Value of net income/loss | 2017-12-31 | $31,279,407 |
Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $264,164,579 |
Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $232,885,172 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2017-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $195,624,241 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $164,079,163 |
Interest on participant loans | 2017-12-31 | $167,880 |
Value of interest in master investment trust accounts at end of year | 2017-12-31 | $44,427,390 |
Value of interest in master investment trust accounts at beginning of year | 2017-12-31 | $45,663,109 |
Value of interest in common/collective trusts at end of year | 2017-12-31 | $19,508,892 |
Value of interest in common/collective trusts at beginning of year | 2017-12-31 | $19,208,963 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-12-31 | $18,572,596 |
Net investment gain or loss from common/collective trusts | 2017-12-31 | $375,489 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2017-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2017-12-31 | No |
Contributions received in cash from employer | 2017-12-31 | $6,462,841 |
Employer contributions (assets) at end of year | 2017-12-31 | $847,156 |
Employer contributions (assets) at beginning of year | 2017-12-31 | $132,995 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2017-12-31 | $27,799,725 |
Did the plan have assets held for investment | 2017-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2017-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2017-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2017-12-31 | Unqualified |
Accountancy firm name | 2017-12-31 | FISCHER CUNNANE & ASSOCIATES, LTD |
Accountancy firm EIN | 2017-12-31 | 233060583 |
2016 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2016 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2016-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
Total income from all sources (including contributions) | 2016-12-31 | $46,801,453 |
Total loss/gain on sale of assets | 2016-12-31 | $0 |
Total of all expenses incurred | 2016-12-31 | $17,891,904 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-12-31 | $17,809,193 |
Expenses. Certain deemed distributions of participant loans | 2016-12-31 | $11,206 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-12-31 | $17,346,657 |
Value of total assets at end of year | 2016-12-31 | $232,885,172 |
Value of total assets at beginning of year | 2016-12-31 | $203,975,623 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2016-12-31 | $71,505 |
Total interest from all sources | 2016-12-31 | $152,654 |
Total dividends received (eg from common stock, registered investment company shares) | 2016-12-31 | $6,600,535 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2016-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2016-12-31 | $6,600,535 |
Was this plan covered by a fidelity bond | 2016-12-31 | Yes |
Value of fidelity bond cover | 2016-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2016-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2016-12-31 | No |
Contributions received from participants | 2016-12-31 | $10,093,472 |
Participant contributions at end of year | 2016-12-31 | $3,800,942 |
Participant contributions at beginning of year | 2016-12-31 | $3,484,623 |
Income. Received or receivable in cash from other sources (including rollovers) | 2016-12-31 | $2,339,525 |
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2016-12-31 | $160 |
Administrative expenses (other) incurred | 2016-12-31 | $71,505 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
Value of net income/loss | 2016-12-31 | $28,909,549 |
Value of net assets at end of year (total assets less liabilities) | 2016-12-31 | $232,885,172 |
Value of net assets at beginning of year (total assets less liabilities) | 2016-12-31 | $203,975,623 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2016-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2016-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2016-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2016-12-31 | $164,079,163 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2016-12-31 | $143,525,520 |
Interest on participant loans | 2016-12-31 | $152,654 |
Value of interest in master investment trust accounts at end of year | 2016-12-31 | $45,663,109 |
Value of interest in master investment trust accounts at beginning of year | 2016-12-31 | $36,998,618 |
Value of interest in common/collective trusts at end of year | 2016-12-31 | $19,208,963 |
Value of interest in common/collective trusts at beginning of year | 2016-12-31 | $19,844,648 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2016-12-31 | $7,712,898 |
Net investment gain or loss from common/collective trusts | 2016-12-31 | $387,626 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2016-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2016-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2016-12-31 | No |
Contributions received in cash from employer | 2016-12-31 | $4,913,660 |
Employer contributions (assets) at end of year | 2016-12-31 | $132,995 |
Employer contributions (assets) at beginning of year | 2016-12-31 | $122,214 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2016-12-31 | $17,809,033 |
Did the plan have assets held for investment | 2016-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2016-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2016-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2016-12-31 | Unqualified |
Accountancy firm name | 2016-12-31 | FISCHER CUNNANE & ASSOCIATES, LTD |
Accountancy firm EIN | 2016-12-31 | 233060583 |
2015 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2015 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2015-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
Total income from all sources (including contributions) | 2015-12-31 | $19,897,199 |
Total loss/gain on sale of assets | 2015-12-31 | $0 |
Total of all expenses incurred | 2015-12-31 | $17,899,453 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2015-12-31 | $17,829,762 |
Expenses. Certain deemed distributions of participant loans | 2015-12-31 | $-67 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2015-12-31 | $14,933,279 |
Value of total assets at end of year | 2015-12-31 | $203,975,623 |
Value of total assets at beginning of year | 2015-12-31 | $201,977,877 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2015-12-31 | $69,758 |
Total interest from all sources | 2015-12-31 | $151,301 |
Total dividends received (eg from common stock, registered investment company shares) | 2015-12-31 | $6,625,185 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2015-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2015-12-31 | $6,625,185 |
Was this plan covered by a fidelity bond | 2015-12-31 | Yes |
Value of fidelity bond cover | 2015-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2015-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2015-12-31 | No |
Contributions received from participants | 2015-12-31 | $9,496,179 |
Participant contributions at end of year | 2015-12-31 | $3,484,623 |
Participant contributions at beginning of year | 2015-12-31 | $3,525,006 |
Income. Received or receivable in cash from other sources (including rollovers) | 2015-12-31 | $731,709 |
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2015-12-31 | $1,443 |
Administrative expenses (other) incurred | 2015-12-31 | $69,758 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
Value of net income/loss | 2015-12-31 | $1,997,746 |
Value of net assets at end of year (total assets less liabilities) | 2015-12-31 | $203,975,623 |
Value of net assets at beginning of year (total assets less liabilities) | 2015-12-31 | $201,977,877 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2015-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2015-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2015-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2015-12-31 | $143,525,520 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2015-12-31 | $110,590,726 |
Interest on participant loans | 2015-12-31 | $151,301 |
Value of interest in master investment trust accounts at end of year | 2015-12-31 | $36,998,618 |
Value of interest in master investment trust accounts at beginning of year | 2015-12-31 | $37,962,711 |
Value of interest in common/collective trusts at end of year | 2015-12-31 | $19,844,648 |
Value of interest in common/collective trusts at beginning of year | 2015-12-31 | $49,789,932 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2015-12-31 | $-7,464,875 |
Net investment gain or loss from common/collective trusts | 2015-12-31 | $782,927 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2015-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2015-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2015-12-31 | No |
Contributions received in cash from employer | 2015-12-31 | $4,705,391 |
Employer contributions (assets) at end of year | 2015-12-31 | $122,214 |
Employer contributions (assets) at beginning of year | 2015-12-31 | $109,502 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2015-12-31 | $17,828,319 |
Did the plan have assets held for investment | 2015-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2015-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2015-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2015-12-31 | Unqualified |
Accountancy firm name | 2015-12-31 | FISCHER CUNNANE & ASSOCIATES, LTD |
Accountancy firm EIN | 2015-12-31 | 233060583 |
2014 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2014 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2014-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $0 |
Total income from all sources (including contributions) | 2014-12-31 | $29,795,774 |
Total loss/gain on sale of assets | 2014-12-31 | $0 |
Total of all expenses incurred | 2014-12-31 | $16,513,382 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2014-12-31 | $16,493,288 |
Expenses. Certain deemed distributions of participant loans | 2014-12-31 | $-1,616 |
Value of total corrective distributions | 2014-12-31 | $1,762 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2014-12-31 | $14,166,634 |
Value of total assets at end of year | 2014-12-31 | $201,977,877 |
Value of total assets at beginning of year | 2014-12-31 | $188,695,485 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2014-12-31 | $19,948 |
Total interest from all sources | 2014-12-31 | $142,389 |
Total dividends received (eg from common stock, registered investment company shares) | 2014-12-31 | $7,075,773 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2014-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2014-12-31 | $7,075,773 |
Was this plan covered by a fidelity bond | 2014-12-31 | Yes |
Value of fidelity bond cover | 2014-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2014-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2014-12-31 | No |
Contributions received from participants | 2014-12-31 | $8,519,788 |
Participant contributions at end of year | 2014-12-31 | $3,525,006 |
Participant contributions at beginning of year | 2014-12-31 | $3,382,552 |
Income. Received or receivable in cash from other sources (including rollovers) | 2014-12-31 | $1,474,147 |
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2014-12-31 | $171 |
Other income not declared elsewhere | 2014-12-31 | $-1 |
Administrative expenses (other) incurred | 2014-12-31 | $19,948 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
Value of net income/loss | 2014-12-31 | $13,282,392 |
Value of net assets at end of year (total assets less liabilities) | 2014-12-31 | $201,977,877 |
Value of net assets at beginning of year (total assets less liabilities) | 2014-12-31 | $188,695,485 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2014-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2014-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2014-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2014-12-31 | $110,590,726 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2014-12-31 | $125,173,726 |
Interest on participant loans | 2014-12-31 | $142,389 |
Value of interest in master investment trust accounts at end of year | 2014-12-31 | $37,962,711 |
Value of interest in master investment trust accounts at beginning of year | 2014-12-31 | $39,532,658 |
Value of interest in common/collective trusts at end of year | 2014-12-31 | $49,789,932 |
Value of interest in common/collective trusts at beginning of year | 2014-12-31 | $20,517,515 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2014-12-31 | $4,431,624 |
Net investment gain or loss from common/collective trusts | 2014-12-31 | $909,125 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2014-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2014-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2014-12-31 | No |
Contributions received in cash from employer | 2014-12-31 | $4,172,699 |
Employer contributions (assets) at end of year | 2014-12-31 | $109,502 |
Employer contributions (assets) at beginning of year | 2014-12-31 | $89,034 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2014-12-31 | $16,493,117 |
Did the plan have assets held for investment | 2014-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2014-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2014-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2014-12-31 | Unqualified |
Accountancy firm name | 2014-12-31 | FISCHER CUNNANE & ASSOCIATES, LTD |
Accountancy firm EIN | 2014-12-31 | 233060583 |
2013 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2013 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2013-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $0 |
Total income from all sources (including contributions) | 2013-12-31 | $57,198,777 |
Total loss/gain on sale of assets | 2013-12-31 | $0 |
Total of all expenses incurred | 2013-12-31 | $15,496,092 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2013-12-31 | $15,486,181 |
Expenses. Certain deemed distributions of participant loans | 2013-12-31 | $-5,434 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2013-12-31 | $12,346,370 |
Value of total assets at end of year | 2013-12-31 | $188,695,485 |
Value of total assets at beginning of year | 2013-12-31 | $146,992,800 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2013-12-31 | $15,345 |
Total interest from all sources | 2013-12-31 | $130,308 |
Total dividends received (eg from common stock, registered investment company shares) | 2013-12-31 | $4,269,353 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2013-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2013-12-31 | $4,269,353 |
Was this plan covered by a fidelity bond | 2013-12-31 | Yes |
Value of fidelity bond cover | 2013-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2013-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2013-12-31 | No |
Contributions received from participants | 2013-12-31 | $7,652,580 |
Participant contributions at end of year | 2013-12-31 | $3,382,552 |
Participant contributions at beginning of year | 2013-12-31 | $2,922,041 |
Income. Received or receivable in cash from other sources (including rollovers) | 2013-12-31 | $889,817 |
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2013-12-31 | $94,153 |
Other income not declared elsewhere | 2013-12-31 | $100 |
Administrative expenses (other) incurred | 2013-12-31 | $15,345 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
Value of net income/loss | 2013-12-31 | $41,702,685 |
Value of net assets at end of year (total assets less liabilities) | 2013-12-31 | $188,695,485 |
Value of net assets at beginning of year (total assets less liabilities) | 2013-12-31 | $146,992,800 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2013-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2013-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2013-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2013-12-31 | $125,173,726 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2013-12-31 | $98,622,439 |
Interest on participant loans | 2013-12-31 | $130,308 |
Value of interest in master investment trust accounts at end of year | 2013-12-31 | $39,532,658 |
Value of interest in master investment trust accounts at beginning of year | 2013-12-31 | $25,219,041 |
Value of interest in common/collective trusts at end of year | 2013-12-31 | $20,517,515 |
Value of interest in common/collective trusts at beginning of year | 2013-12-31 | $20,106,284 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2013-12-31 | $21,814,946 |
Net investment gain or loss from common/collective trusts | 2013-12-31 | $-129,313 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2013-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2013-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2013-12-31 | No |
Contributions received in cash from employer | 2013-12-31 | $3,803,973 |
Employer contributions (assets) at end of year | 2013-12-31 | $89,034 |
Employer contributions (assets) at beginning of year | 2013-12-31 | $122,995 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2013-12-31 | $15,392,028 |
Did the plan have assets held for investment | 2013-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2013-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2013-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2013-12-31 | Unqualified |
Accountancy firm name | 2013-12-31 | FISCHER CUNNANE & ASSOCIATES,LTD |
Accountancy firm EIN | 2013-12-31 | 233060583 |
2012 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2012 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2012-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $0 |
Total income from all sources (including contributions) | 2012-12-31 | $33,057,957 |
Total loss/gain on sale of assets | 2012-12-31 | $0 |
Total of all expenses incurred | 2012-12-31 | $12,180,207 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2012-12-31 | $12,156,633 |
Expenses. Certain deemed distributions of participant loans | 2012-12-31 | $8,895 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2012-12-31 | $11,343,488 |
Value of total assets at end of year | 2012-12-31 | $146,992,800 |
Value of total assets at beginning of year | 2012-12-31 | $126,115,050 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2012-12-31 | $14,679 |
Total interest from all sources | 2012-12-31 | $121,881 |
Total dividends received (eg from common stock, registered investment company shares) | 2012-12-31 | $2,489,192 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2012-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2012-12-31 | $2,489,192 |
Was this plan covered by a fidelity bond | 2012-12-31 | Yes |
Value of fidelity bond cover | 2012-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2012-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2012-12-31 | No |
Contributions received from participants | 2012-12-31 | $7,122,400 |
Participant contributions at end of year | 2012-12-31 | $2,922,041 |
Participant contributions at beginning of year | 2012-12-31 | $2,764,531 |
Income. Received or receivable in cash from other sources (including rollovers) | 2012-12-31 | $621,009 |
Administrative expenses (other) incurred | 2012-12-31 | $14,679 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2012-12-31 | No |
Value of net income/loss | 2012-12-31 | $20,877,750 |
Value of net assets at end of year (total assets less liabilities) | 2012-12-31 | $146,992,800 |
Value of net assets at beginning of year (total assets less liabilities) | 2012-12-31 | $126,115,050 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2012-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2012-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2012-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2012-12-31 | $98,622,439 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2012-12-31 | $82,803,648 |
Interest on participant loans | 2012-12-31 | $121,881 |
Value of interest in master investment trust accounts at end of year | 2012-12-31 | $25,219,041 |
Value of interest in master investment trust accounts at beginning of year | 2012-12-31 | $20,418,526 |
Value of interest in common/collective trusts at end of year | 2012-12-31 | $20,106,284 |
Value of interest in common/collective trusts at beginning of year | 2012-12-31 | $20,041,164 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2012-12-31 | $9,763,149 |
Net investment gain or loss from common/collective trusts | 2012-12-31 | $512,269 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2012-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2012-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2012-12-31 | No |
Contributions received in cash from employer | 2012-12-31 | $3,600,079 |
Employer contributions (assets) at end of year | 2012-12-31 | $122,995 |
Employer contributions (assets) at beginning of year | 2012-12-31 | $87,181 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2012-12-31 | $12,156,633 |
Did the plan have assets held for investment | 2012-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2012-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2012-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2012-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2012-12-31 | Unqualified |
Accountancy firm name | 2012-12-31 | FISCHER CUNNANE & ASSOCIATES, LTD |
Accountancy firm EIN | 2012-12-31 | 233060583 |
2011 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2011 401k financial data | ||
Total unrealized appreciation/depreciation of assets | 2011-12-31 | $0 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $0 |
Total income from all sources (including contributions) | 2011-12-31 | $10,609,969 |
Total loss/gain on sale of assets | 2011-12-31 | $0 |
Total of all expenses incurred | 2011-12-31 | $12,896,469 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2011-12-31 | $12,881,687 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2011-12-31 | $10,810,345 |
Value of total assets at end of year | 2011-12-31 | $126,115,050 |
Value of total assets at beginning of year | 2011-12-31 | $128,401,550 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2011-12-31 | $14,782 |
Total interest from all sources | 2011-12-31 | $122,024 |
Total dividends received (eg from common stock, registered investment company shares) | 2011-12-31 | $2,131,716 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2011-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2011-12-31 | $2,131,716 |
Was this plan covered by a fidelity bond | 2011-12-31 | Yes |
Value of fidelity bond cover | 2011-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2011-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2011-12-31 | No |
Contributions received from participants | 2011-12-31 | $6,930,865 |
Participant contributions at end of year | 2011-12-31 | $2,764,531 |
Participant contributions at beginning of year | 2011-12-31 | $2,608,785 |
Income. Received or receivable in cash from other sources (including rollovers) | 2011-12-31 | $397,463 |
Administrative expenses (other) incurred | 2011-12-31 | $14,782 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2011-12-31 | No |
Value of net income/loss | 2011-12-31 | $-2,286,500 |
Value of net assets at end of year (total assets less liabilities) | 2011-12-31 | $126,115,050 |
Value of net assets at beginning of year (total assets less liabilities) | 2011-12-31 | $128,401,550 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2011-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2011-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2011-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2011-12-31 | $82,803,648 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2011-12-31 | $81,975,121 |
Interest on participant loans | 2011-12-31 | $122,024 |
Value of interest in master investment trust accounts at end of year | 2011-12-31 | $20,418,526 |
Value of interest in master investment trust accounts at beginning of year | 2011-12-31 | $0 |
Value of interest in common/collective trusts at end of year | 2011-12-31 | $20,041,164 |
Value of interest in common/collective trusts at beginning of year | 2011-12-31 | $17,607,772 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2011-12-31 | $-2,722,265 |
Net investment gain or loss from common/collective trusts | 2011-12-31 | $1,455,089 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2011-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2011-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2011-12-31 | No |
Assets. Invements in employer securities at end of year | 2011-12-31 | $0 |
Assets. Invements in employer securities at beginning of year | 2011-12-31 | $26,159,931 |
Contributions received in cash from employer | 2011-12-31 | $3,482,017 |
Employer contributions (assets) at end of year | 2011-12-31 | $87,181 |
Employer contributions (assets) at beginning of year | 2011-12-31 | $49,941 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2011-12-31 | $12,881,687 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2011-12-31 | No |
Did the plan have assets held for investment | 2011-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2011-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2011-12-31 | No |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2011-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2011-12-31 | Unqualified |
Accountancy firm name | 2011-12-31 | FISCHER CUNNANE & ASSOCIATES, LTD |
Accountancy firm EIN | 2011-12-31 | 233060583 |
2010 : WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2010 401k financial data | ||
Unrealized appreciation/depreciation of other (non real estate) assets | 2010-12-31 | $1,249,692 |
Total unrealized appreciation/depreciation of assets | 2010-12-31 | $1,249,692 |
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $0 |
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $0 |
Total income from all sources (including contributions) | 2010-12-31 | $22,045,392 |
Total loss/gain on sale of assets | 2010-12-31 | $-29,314 |
Total of all expenses incurred | 2010-12-31 | $8,694,282 |
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2010-12-31 | $8,680,573 |
Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2010-12-31 | $10,389,764 |
Value of total assets at end of year | 2010-12-31 | $128,401,550 |
Value of total assets at beginning of year | 2010-12-31 | $115,050,440 |
Total of administrative expenses incurred including professional, contract, advisory and management fees | 2010-12-31 | $13,709 |
Total interest from all sources | 2010-12-31 | $125,220 |
Total dividends received (eg from common stock, registered investment company shares) | 2010-12-31 | $1,880,328 |
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2010-12-31 | No |
Total dividends received from registered investment company shares (eg mutual funds) | 2010-12-31 | $1,444,177 |
Was this plan covered by a fidelity bond | 2010-12-31 | Yes |
Value of fidelity bond cover | 2010-12-31 | $5,000,000 |
If this is an individual account plan, was there a blackout period | 2010-12-31 | No |
Were there any nonexempt tranactions with any party-in-interest | 2010-12-31 | No |
Contributions received from participants | 2010-12-31 | $6,782,907 |
Participant contributions at end of year | 2010-12-31 | $2,608,785 |
Participant contributions at beginning of year | 2010-12-31 | $2,185,828 |
Income. Received or receivable in cash from other sources (including rollovers) | 2010-12-31 | $275,502 |
Other income not declared elsewhere | 2010-12-31 | $2,451 |
Administrative expenses (other) incurred | 2010-12-31 | $13,709 |
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2010-12-31 | No |
Value of net income/loss | 2010-12-31 | $13,351,110 |
Value of net assets at end of year (total assets less liabilities) | 2010-12-31 | $128,401,550 |
Value of net assets at beginning of year (total assets less liabilities) | 2010-12-31 | $115,050,440 |
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2010-12-31 | No |
Were any loans by the plan or fixed income obligations due to the plan in default | 2010-12-31 | No |
Were any leases to which the plan was party in default or uncollectible | 2010-12-31 | No |
Value of interest in registered invesment companies (eg mutual funds) at end of year | 2010-12-31 | $81,975,121 |
Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2010-12-31 | $68,081,532 |
Interest on participant loans | 2010-12-31 | $125,220 |
Value of interest in common/collective trusts at end of year | 2010-12-31 | $17,607,772 |
Value of interest in common/collective trusts at beginning of year | 2010-12-31 | $17,358,105 |
Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2010-12-31 | $7,932,081 |
Net investment gain or loss from common/collective trusts | 2010-12-31 | $495,170 |
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2010-12-31 | No |
Was there a failure to transmit to the plan any participant contributions | 2010-12-31 | No |
Has the plan failed to provide any benefit when due under the plan | 2010-12-31 | No |
Assets. Invements in employer securities at end of year | 2010-12-31 | $26,159,931 |
Assets. Invements in employer securities at beginning of year | 2010-12-31 | $27,314,051 |
Contributions received in cash from employer | 2010-12-31 | $3,331,355 |
Employer contributions (assets) at end of year | 2010-12-31 | $49,941 |
Employer contributions (assets) at beginning of year | 2010-12-31 | $110,924 |
Income. Dividends from common stock | 2010-12-31 | $436,151 |
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2010-12-31 | $8,680,573 |
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2010-12-31 | No |
Did the plan have assets held for investment | 2010-12-31 | Yes |
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2010-12-31 | No |
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2010-12-31 | No |
Aggregate proceeds on sale of assets | 2010-12-31 | $3,581,363 |
Aggregate carrying amount (costs) on sale of assets | 2010-12-31 | $3,610,677 |
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2010-12-31 | No |
Opinion of an independent qualified public accountant for this plan | 2010-12-31 | Unqualified |
Accountancy firm name | 2010-12-31 | FISCHER CUNNANE AND ASSOCIATES, LTD |
Accountancy firm EIN | 2010-12-31 | 233060583 |
2022: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2022 form 5500 responses | ||
---|---|---|
2022-01-01 | Type of plan entity | Single employer plan |
2022-01-01 | Submission has been amended | No |
2022-01-01 | This submission is the final filing | No |
2022-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2022-01-01 | Plan is a collectively bargained plan | No |
2022-01-01 | Plan funding arrangement – Trust | Yes |
2022-01-01 | Plan benefit arrangement - Trust | Yes |
2021: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2021 form 5500 responses | ||
2021-01-01 | Type of plan entity | Single employer plan |
2021-01-01 | Submission has been amended | No |
2021-01-01 | This submission is the final filing | No |
2021-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2021-01-01 | Plan is a collectively bargained plan | No |
2021-01-01 | Plan funding arrangement – Trust | Yes |
2021-01-01 | Plan benefit arrangement - Trust | Yes |
2020: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2020 form 5500 responses | ||
2020-01-01 | Type of plan entity | Single employer plan |
2020-01-01 | Submission has been amended | No |
2020-01-01 | This submission is the final filing | No |
2020-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2020-01-01 | Plan is a collectively bargained plan | No |
2020-01-01 | Plan funding arrangement – Trust | Yes |
2020-01-01 | Plan benefit arrangement - Trust | Yes |
2019: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2019 form 5500 responses | ||
2019-01-01 | Type of plan entity | Single employer plan |
2019-01-01 | Submission has been amended | No |
2019-01-01 | This submission is the final filing | No |
2019-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2019-01-01 | Plan is a collectively bargained plan | No |
2019-01-01 | Plan funding arrangement – Trust | Yes |
2019-01-01 | Plan benefit arrangement - Trust | Yes |
2018: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2018 form 5500 responses | ||
2018-01-01 | Type of plan entity | Single employer plan |
2018-01-01 | Submission has been amended | No |
2018-01-01 | This submission is the final filing | No |
2018-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2018-01-01 | Plan is a collectively bargained plan | No |
2018-01-01 | Plan funding arrangement – Trust | Yes |
2018-01-01 | Plan benefit arrangement - Trust | Yes |
2017: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2017 form 5500 responses | ||
2017-01-01 | Type of plan entity | Single employer plan |
2017-01-01 | Submission has been amended | No |
2017-01-01 | This submission is the final filing | No |
2017-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2017-01-01 | Plan is a collectively bargained plan | No |
2017-01-01 | Plan funding arrangement – Trust | Yes |
2017-01-01 | Plan benefit arrangement - Trust | Yes |
2016: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2016 form 5500 responses | ||
2016-01-01 | Type of plan entity | Single employer plan |
2016-01-01 | Submission has been amended | No |
2016-01-01 | This submission is the final filing | No |
2016-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2016-01-01 | Plan is a collectively bargained plan | No |
2016-01-01 | Plan funding arrangement – Trust | Yes |
2016-01-01 | Plan benefit arrangement - Trust | Yes |
2015: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2015 form 5500 responses | ||
2015-01-01 | Type of plan entity | Single employer plan |
2015-01-01 | Submission has been amended | No |
2015-01-01 | This submission is the final filing | No |
2015-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2015-01-01 | Plan is a collectively bargained plan | No |
2015-01-01 | Plan funding arrangement – Trust | Yes |
2015-01-01 | Plan benefit arrangement - Trust | Yes |
2014: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2014 form 5500 responses | ||
2014-01-01 | Type of plan entity | Single employer plan |
2014-01-01 | Submission has been amended | No |
2014-01-01 | This submission is the final filing | No |
2014-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2014-01-01 | Plan is a collectively bargained plan | No |
2014-01-01 | Plan funding arrangement – Trust | Yes |
2014-01-01 | Plan benefit arrangement - Trust | Yes |
2013: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2013 form 5500 responses | ||
2013-01-01 | Type of plan entity | Single employer plan |
2013-01-01 | Submission has been amended | No |
2013-01-01 | This submission is the final filing | No |
2013-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2013-01-01 | Plan is a collectively bargained plan | No |
2013-01-01 | Plan funding arrangement – Trust | Yes |
2013-01-01 | Plan benefit arrangement - Trust | Yes |
2012: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2012 form 5500 responses | ||
2012-01-01 | Type of plan entity | Single employer plan |
2012-01-01 | Submission has been amended | No |
2012-01-01 | This submission is the final filing | No |
2012-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2012-01-01 | Plan is a collectively bargained plan | No |
2012-01-01 | Plan funding arrangement – Trust | Yes |
2012-01-01 | Plan benefit arrangement - Trust | Yes |
2011: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2011 form 5500 responses | ||
2011-01-01 | Type of plan entity | Single employer plan |
2011-01-01 | Submission has been amended | No |
2011-01-01 | This submission is the final filing | No |
2011-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2011-01-01 | Plan is a collectively bargained plan | No |
2011-01-01 | Plan funding arrangement – Trust | Yes |
2011-01-01 | Plan benefit arrangement - Trust | Yes |
2010: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2010 form 5500 responses | ||
2010-01-01 | Type of plan entity | Single employer plan |
2010-01-01 | Submission has been amended | No |
2010-01-01 | This submission is the final filing | No |
2010-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2010-01-01 | Plan is a collectively bargained plan | No |
2010-01-01 | Plan funding arrangement – Trust | Yes |
2010-01-01 | Plan benefit arrangement - Trust | Yes |
2009: WEST PHARMACEUTICAL SERVICES, INC. 401(K) PLAN 2009 form 5500 responses | ||
2009-01-01 | Type of plan entity | Single employer plan |
2009-01-01 | Submission has been amended | No |
2009-01-01 | This submission is the final filing | No |
2009-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
2009-01-01 | Plan is a collectively bargained plan | No |
2009-01-01 | Plan funding arrangement – Trust | Yes |
2009-01-01 | Plan benefit arrangement - Trust | Yes |